EP3656443
USE OF TRL AGONIST AND ANTI-CD47 AGENT TO ENHANCE PHAGOCYTOSIS OF CANCER CELLS
:
EP einkaleyfi: Þýðing ekki lögð inn:
21.1.2016:
29.9.2021:
19197485.6
:
20.1.2036
:
USE OF TRL AGONIST AND ANTI-CD47 AGENT TO ENHANCE PHAGOCYTOSIS OF CANCER CELLS
21.1.2016
29.9.2021
:
The Board of Trustees of the Leland Stanford Junior University:
Office of the General Counsel Building 170, Third Floor, Main Quad P.O. Box 20386, Stanford, CA 94305-2038, US
:
WEISSMAN, Irving L.:
Stanford, CA California 94305, US
:
FENG, Mingye:
Mountain View, CA California 94040, US
:
VOLKMER, Jens-Peter:
Menlo Park, CA California 94025, US
:
201562106050 P:
21.1.2015:
US
:
A61K 39/39, A61K 39/395, A61K 45/06, A61K 31/4745, A61K 31/713, A61K 35/15, A61P 7/00, A61P 35/00, C07K 16/18, C07K 16/28, A61K 31/519